Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Modulation of Neurocognitive Mechanisms Involved in Inhibitory Control in Tic Disorders

NCT05263414 is registered in ClinicalTrials.gov with IRCCS Eugenio Medea as lead sponsor.

NCT NCT05263414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05263414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Modulation of Neurocognitive Mechanisms Involved in Inhibitory Control in Tic Disorders
Lead sponsor
IRCCS Eugenio Medea
Phase
Not applicable
Overall status
Unknown status
Start date
June 1, 2022
Completion date
April 30, 2023
Enrollment
26 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

tic disorders